Target intelligence / Profile preview

SUMO2 pseudogene 17 (SUMO2P17)

Target
SUMO2P17
Molecular classification
Other, Pseudogene
01

Overview

SUMO2 pseudogene 17 (SUMO2P17) is a nonfunctional genomic sequence related to the SUMO2 gene. SUMO2 encodes Small ubiquitin-like modifier 2, a protein involved in essential cellular processes such as nuclear transport, stress response, and transcriptional regulation. However, pseudogenes like SUMO2P17 typically do not produce functional proteins and are not considered therapeutic targets. The functional SUMO2 protein has broad regulatory roles through post-translational modification but pseudogenes, including SUMO2P17, are generally regarded as “genomic fossils” without well-defined biological or pathological roles. SUMO2P17 should not be considered a therapeutic target. If you intend to refer to the functional post-translational modifier, you should search for “Small ubiquitin-like modifier 2 (SUMO2)” instead. The pseudogene status (“pseudogene 17”) means it is a duplicated sequence in the genome that does not produce the SUMO2 protein and thus has no direct biological activity.

Other names
SUMO2P17
02

Mechanism of action

Null (Not a protein, so no direct mechanism of action.)

Beyond the preview

Go deeper on SUMO2 pseudogene 17 (SUMO2P17).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on SUMO2 pseudogene 17 (SUMO2P17).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call